Genomic Vision 

0
0
+€0.00+0% 00:00 今日

統計

日中高値
-
日中安値
-
52週高値
-
52週安値
-
出来高
-
平均出来高
-
時価総額
0
PER
-
配当利回り
-
配当
-

競合他社

このリストは最近の市場イベントに基づく分析です。投資推奨ではありません。

概要

Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides CombHeliX FSHD probes for the diagnosis of facioscapulohumeral dystrophy; FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur; and development agreement with Integrated Technologies Ltd for the design and development of a high-throughput scanning instrument for molecular combing assays. The company was founded in 2004 and is headquartered in Bagneux, France.
もっと見る
CEO
Mr. Aaron Bensimon
従業員
27
国
フランス
ISIN
FR0011799907
WKN
000A110TM

上場銘柄

0件のコメント

意見をシェア

よくある質問

Genomic Visionの株式ティッカーは何ですか?▼
取引所によって株式のティッカーは異なる場合があります。たとえば、Boerse Muenchen取引所ではGenomic Visionの株式はティッカーG09.MUで取引されています。
Genomic Vision の従業員数は何人ですか?▼
2026年11月2日時点で、同社の従業員数は27人です。
Genomic Vision はどのセクターに属していますか?▼
Genomic Visionはヘルス&ウェルネスセクターで事業を行っています。
Genomic Vision はいつ株式分割を実施しましたか?▼
Genomic Visionは最近株分割を行っていません。
Genomic Vision の本社はどこですか?▼
Genomic Vision の本社は フランス の Bagneux にあります。